Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer’s disease ; volume:5 ; number:1 ; day:31 ; month:1 ; year:2017 ; pages:1-9 ; date:12.2017
Acta Neuropathologica Communications ; 5, Heft 1 (31.1.2017), 1-9, 12.2017
- Schlagwort
-
Kardiovaskuläre Krankheit
- Urheber
-
Hara, Norikazu
- Beteiligte Personen und Organisationen
-
Kikuchi, Masataka
Miyashita, Akinori
Hatsuta, Hiroyuki
Saito, Yuko
Kasuga, Kensaku
Murayama, Shigeo
Ikeuchi, Takeshi
Kuwano, Ryozo
SpringerLink (Online service)
- DOI
-
10.1186/s40478-017-0414-z
- URN
-
urn:nbn:de:1111-201702255640
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hara, Norikazu
- Kikuchi, Masataka
- Miyashita, Akinori
- Hatsuta, Hiroyuki
- Saito, Yuko
- Kasuga, Kensaku
- Murayama, Shigeo
- Ikeuchi, Takeshi
- Kuwano, Ryozo
- SpringerLink (Online service)
Ähnliche Objekte (12)
MicroRNA-29a Is a Candidate Biomarker for Alzheimer’s Disease in Cell-Free Cerebrospinal Fluid
Systematic Analysis and Biomarker Study for Alzheimer’s Disease
Anticipated reactions to learning Alzheimer’s disease biomarker results
MicroRNA-22-3p ameliorates Alzheimer’s disease by targeting SOX9 through the NF-κB signaling pathway in the hippocampus
Neue multimodale Biomarker der Alzheimer-Erkrankung
Amyloid blood biomarker detects Alzheimer's disease
Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
Role of miR-132-3p in the pathogenesis of Alzheimer’s disease
Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer’s Disease
Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
Cognitive biomarker prioritization in Alzheimer’s Disease using brain morphometric data
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
MicroRNA-29a Is a Candidate Biomarker for Alzheimer’s Disease in Cell-Free Cerebrospinal Fluid
Systematic Analysis and Biomarker Study for Alzheimer’s Disease
Anticipated reactions to learning Alzheimer’s disease biomarker results
MicroRNA-22-3p ameliorates Alzheimer’s disease by targeting SOX9 through the NF-κB signaling pathway in the hippocampus
Neue multimodale Biomarker der Alzheimer-Erkrankung
Amyloid blood biomarker detects Alzheimer's disease
Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
Role of miR-132-3p in the pathogenesis of Alzheimer’s disease
Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer’s Disease
Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
Cognitive biomarker prioritization in Alzheimer’s Disease using brain morphometric data
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
MicroRNA-29a Is a Candidate Biomarker for Alzheimer’s Disease in Cell-Free Cerebrospinal Fluid
Systematic Analysis and Biomarker Study for Alzheimer’s Disease
Anticipated reactions to learning Alzheimer’s disease biomarker results
MicroRNA-22-3p ameliorates Alzheimer’s disease by targeting SOX9 through the NF-κB signaling pathway in the hippocampus
Neue multimodale Biomarker der Alzheimer-Erkrankung
Amyloid blood biomarker detects Alzheimer's disease
Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
Role of miR-132-3p in the pathogenesis of Alzheimer’s disease
Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer’s Disease
Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
Cognitive biomarker prioritization in Alzheimer’s Disease using brain morphometric data